The decreased plasma IL-6 level could, therefore, be partly responsible for the attenuation of atherosclerosis in SP-D/ApoE DKO mice, despite the elevated body weight and plasma lipoproteins, which are known risk factors for the development of CVD (86–90). Here, APOE is linked to atherosclerosis.